Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 13 , ISSUE 6 ( November-December, 2021 ) > List of Articles

ORIGINAL RESEARCH

A Prospective Comparative Study of Mifepristone and Misoprostol vs Misoprostol Alone for Induction of Labor in Intrauterine Fetal Death

Aarzoo Hoda, Manazir Ali, Ummay K Kulsoom

Keywords : Intrauterine fetal death, Labor induction, Mifepristone, Misoprostol

Citation Information : Hoda A, Ali M, Kulsoom UK. A Prospective Comparative Study of Mifepristone and Misoprostol vs Misoprostol Alone for Induction of Labor in Intrauterine Fetal Death. J South Asian Feder Obs Gynae 2021; 13 (6):355-358.

DOI: 10.5005/jp-journals-10006-1942

License: CC BY-NC 4.0

Published Online: 04-03-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Introduction: Intrauterine fetal death (IUFD) is an important indicator of maternal and perinatal health of a given population. Aim and objective: The objective of the study was to assess the efficacy of mifepristone and misoprostol vs misoprostol alone for induction of labor in IUFD and to determine risk-benefit ratio. Materials and methods: The present study was a prospective observational analytical study which was conducted in the Department of Obstetrics and Gynecology, JNMCH, Aligarh, from January 2018 to January 2021and includes 110 pregnant women with confirmed IUFD on USG. After taking informed consent, a predesigned pro forma was used to collect relevant sociodemographic profile, detailed logical history, and examination from all those participating in the study. Results: Age (mean ± SD) was 25.98 ± 4.49 vs 25.69 ± 4.78 years, parity was 2.31 ± 1.3 vs 2.44 ± 1.61, and gestational age was 31.04 ± 6.89 vs 32.71 ± 5.17 weeks in group I and group II, respectively. Modified Bishops score was >6 in 35 (63.64%) vs 32 (14.55%) women, mean dose of misoprostol required was 0.95 ± 1.5 vs 2.64 ± 1.89, mean induction labor interval was 2.42 vs 7.53 hours, and mean induction to delivery interval was 6.68 vs 16.61 hours in group I and group II, respectively, and the difference was found to be statistically significant. Mean birth weight was 1431.35 vs 1758.60 g, respectively, in the two groups. Four women (7.27%) in group I and 17 women (30.9%) in group II required augmentation with oxytocin which is statistically significant. Nausea, vomiting, loose stools, and hyperthermia were recorded as adverse effects. Among the identifiable causes, abruption was the most common cause in group II, whereas anemia and preeclampsia in group I. Conclusion: The combination of mifepristone with misoprostol was more effective for the induction of labor in IUFD, in terms of lesser amount of misoprostol dosage, oxytocin augmentation, improvement in modified Bishops score, and shorter induction labor and delivery interval when compared to misoprostol alone. Both the regimens were equally safe and easy to administer.


HTML PDF Share
  1. Mac Dorman MF, Gregory EC. Fetal and perinatal mortality, United States, 2013. Natl Vital Stat Rep 2015;64(8):1. PMID: 26222771.
  2. Mac Dorman MF, Kirmeyer SE, Wilson EC. Fetal and perinatal mortality. Natl Vital Stat Rep 2006;60(8):23. PMID: 24979970.
  3. Tempfer CB, Brunner A, Bentz EK, et al. Intrauterine fetal death and delivery complications associated with coagulopathy: a retrospective analysis of 104 cases. J Women's Health 2009;18(4):469–474. DOI: 10.1089/jwh.2008.0938.
  4. Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: regimen efficacy, acceptability, and future directions. Am J Obstet Gynecol 2000;182(2 Suppl.):44–53. DOI: 10.1067/mob.2000. 107950.
  5. El-Refacy H, Rajashekhar. D, Abdalla M, et al. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J M 1995;332(15):983. DOI: 10.1056/NEJM199504133321502.
  6. Ashok PW, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13(100):2962–2965. DOI: 10.1093/humrep/13.10.2962.
  7. Borgatta L, Kapp N. Clinical guidelines: labour induction abortion in the second trimester. Contraception 2011;84(1):4–18. DOI: 10.1016/j.contraception.2011.02.005.
  8. Sindhuri TR, Samal S, Gupta S, et al. Effect of mifepristone misoprostol versus misoprostol in the management of intrauterine fetal death. Arch Med Health Sci 2020;8(2):202–207. DOI: 10.4103/amhs. amhs_209_20.
  9. Hemalatha KR, Mulla QK. Comparative study of mifepristone and misoprostol versus misoprostol in the induction of labor in late intrauterine fetal death. Int J Reprod Contracept Obstet Gynecol 2018;7(3):987–990. DOI: 10.18203/2320-1770.ijrcog20180878.
  10. Trivedi K, Swati A, Shrivastava P, et al. Mifepristone followed by prostaglandins vs prostaglandins alone for induction of labor in intrauterine fetal death at or more than 28 weeks of pregnancy. Int J Contemp Med Res 2019;6(10). DOI: 10.21276/ijcmr.2019.6.10.24.
  11. Arjunan Y, Nichanahalli KS, Pampapati V, et al. Oral misoprostol with mifepristone versus misoprostol for inducing labor in intrauterine fetal death. Int J Adv Med Health Res 2017;4(1):23–26. DOI: 10.4103/IJAMR.IJAMR_70_16.
  12. Modak R, Roy S, Biswas DK, et al. Role of combination of mifepristone and misoprostol versus misoprostol alone in induction of labor in late intrauterine fetal death: a randomized trial. Int J Clin Obstet Gynecol 2018;2(6):78–82.
  13. Panda S, Jha V, Singh S. Role of a combination of Mifepristone and Misoprostol versus misoprostol alone in Induction of labor in late intrauterine fetal death. J Family Reprod Health 2013;7(4):177–179. PMID: 24971122.
  14. Sharma D, Singhal SR, Poonam, et al. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine fetal death. Taiwan J Obstet Gynecol 2011;50(3):322–325. DOI: 10.1016/j.tjog.2011.07.007.
  15. Maheshwari S, Borgohain D. Methods of induction of labor in intrauterine fetal demise. Int J Reprod Contracept Obstet Gynecol 2017;6(9):3911–3914. DOI: 10.18203/2320-1770.ijrcog20174033.
  16. Gupta S, Kagathra B, Desai A. Mifepristone and misoprostol versus misoprostol alone in the management of late intrauterine fetal death: Int J Reprod Contracept Obstet Gynecol 2016;5(9):2935–2938. DOI: 10.18203/2320-1770.ijrcog20162882.
  17. Agrawal A, Basnet P, Thakur A, et al. Induction of labor using misoprostol with or without mifepristone in intrauterine death. JNMA J Nepal Med Assoc 2014;52(194):785–790. PMID: 26905705.
  18. Väyrynen W, Heikinheimo O, Muutila A. Misoprostolonly versus mifepristone plus misoprostol in the induction of labor following intrauterine fetal death. Acta Obstet Gynecol Scand 2007;86(6): 701–705. DOI: 10.1080/00016340701379853.
  19. Praveena G, Shameem VP, Rao A, et al. Mifepristone plus misoprostol versus only misoprostol in the induction of labor in intrauterine fetal death. Int J Pharm Biomed Res 2013;4:108–110. DOI: 10.18203/2320-1770.ijrcog201.
  20. Ngoc NT, Shochet T, Raghavan S, et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol 2011;118(3):601–608. DOI: 10.1097/AOG.0b013e318227214e.
  21. Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second-trimester termination of pregnancy. J Obstet Gynaecol India 2011;61(6):659–662. DOI: 10.1007/s13224-011-0118-4.
  22. Abbasi S, Siddiqua SF, Alam MN, et al. Role of combined mifepristone and misoprostol vs misoprostol alone in the induction of labor in patients with an intrauterine fetal death: a randomized comparison between their outcome. Anwer Khan Mod Med Coll J 2017;8:50–54. DOI: 10.3329/akmmcj.v8i1.31658.
  23. Wedisinghe L, Elsandabesse D. Flexible mifepristone and misoprostol administration interval for a first-trimester medical termination. Contraception 2010;81(4):269–274. DOI: 10.1016/j.contraception.2009.09.007.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.